Implementation of a multifaceted antimicrobial stewardship program (ASP) in a large community hospital in New Jersey was associated with significant, sustained reductions in unnecessary antibiotic use, Clostridioides difficile infection (CDI) rates, and antimicrobial acquisition costs, researchers reported late last week in Infection Control & Hospital Epidemiology.
A new report from the Centers for Disease Control and Prevention (CDC) shows that progress against healthcare-associated infections (HAIs), including those caused by antibiotic-resistant bacteria, took a step back in 2020.
A pair of values-based incentive programs at US hospitals were linked to a decline in C difficile.
Implementing institution-specific guidelines (ISGs) for antimicrobial prescribing and use of diagnostics at a tertiary care hospital was associated with significant declines in antibiotic resistance rates and Clostridioides difficile infections (CDIs), German researchers reported yesterday in PLOS One.
The World Health Organization (WHO) today recommended the RTS,S malaria vaccine for children in sub-Saharan Africa and other areas of moderate and high Plasmodium falciparum malaria transmission. The recommendation paves the way for global health groups to make funding and vaccine rollout plans and for countries to decide whether to include vaccination in their malaria control programs.
An intervention based on the Centers for Disease Control and Prevention (CDC) Core Elements of Outpatient Antibiotic Stewardship yielded cost savings at 10 outpatient Veterans Healthcare Administration (VHA) sites, researchers reported today in Infection Control & Hospital Epidemiology.
Guidelines published yesterday by the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) contain three new recommendations for treating adults who have Clostridioides difficile infection (CDI).
Data from a cohort of US acute care hospitals (ACHs) reveal an association between total and broad-spectrum antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) rates, researchers from the Centers for Disease Control and Prevention (CDC) reported today in Infection Control & Hospital Epidemiology.
Secondary analysis of patients from a postdischarge decolonization trial of methicillin-resistant Staphylococcus aureus (MRSA) carriers found that re-hospitalization for MRSA was associated with extensive exposure to non-MRSA antibiotics and Clostridioides difficile infection (CDI), researchers reported today in Infection Control & Hospital Epidemiology.
In addition to less antibiotic use, participating hospitals saw a 20% drop in hospital-onset C difficile.
